A carregar...

The use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model

Cryotherapy has emerged as a primary treatment option for prostate cancer(CaP); however, incomplete ablation in the periphery of the cryogenic lesion can lead to recurrence. Accordingly, we investigated the use of a nontoxic adjunctive agent, Vitamin D(3), with cryotherapy to sensitize CaP to low te...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Santucci, Kimberly L., Snyder, Kristi K., Baust, John. M., Van Buskirk, Robert G., Mouraviev, Vladimir, Polascik, Thomas J., Gage, Andrew A., Baust, John G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3094482/
https://ncbi.nlm.nih.gov/pubmed/21221127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2010.52
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!